Jing Tu

Jing Tu is Head of Corporate Development and Strategy at Alliance Pharma (PA, USA). Jing has been working in the CRO and pharmaceutical industry since 2011. She started her career with Frontage Laboratories (PA, USA) in its biologics ligand binding services lab. As a Frontage scientist, she was then selected by Janssen R&D (formerly Centocor) to work within their ligand-binding laboratories in Spring House (PA, USA). In 2015, Jing joined PPD Laboratories’ (VA, USA) biomarker lab and started its biomarker ligand binding assay group. In 2018, Jing Joined the AbbVie (MA, USA) DMPK department and led its pre-clinical large molecule bioanalysis support.

Jing has an M.B.A degree from Yale University (CT, USA) and graduated as the Class Marshall. She also has a medical degree from Norman Bethune School of Medicine Jilin University (Changchun, China).